Sophie Paget-Bailly is a research engineer in epidemiology and clinical research. She passed with honours the East of France inter-region master’s degree in public health and occupational and environmental risks. During the master’s degree’s internship in the Interregional Epidemiology Unit of Bourgogne/Franche-Comté, she realized a quantitative health risk assessment in the context of chemical contamination of groundwater. She defended a PhD in Public Health and Epidemiology in Paris XI University, Doctoral School 420, working in the Centre for Research in Epidemiology and Population Health in Villejuif, France. Her PhD research focused on occupational exposures and head and neck cancer. 



She then joined the UMQVC at the University hospital of Besancon where she provides methodological support for clinicians in designing, analyzing and promoting results from clinical research. She is particularly involved into developing health related quality of life assessment in gyneco-oncology and is also statistical editor among the Cochrane Lung Cancer Group. She also provides lessons in biostatistics to medical school students and in research methodology to public health master’s degree students.

Main areas of expertise

- Epidemiology

- Clinical trials and clinical research

- Biostatistics

- Oncology

- Meta-analyses and Cochrane methodology

- Occupational epidemiology


Main ongoing external collaboration

- Cochrane Lung Cancer Group


Thesis manuscript (hyperlink) 

Latest publications

sample

BACKGROUND:A randomized multicenter phase II trial was conducted to assess the sequential treatment strategy using...

Posted by : Pr. Franck BONNETAIN, Dr. Sophie PAGET-BAILLY, Dr. Guillaume MOUILLET, Dr. Amélie ANOTA
Journal name : PlosOne

sample

Background: Even though the perioperative chemotherapy improves the overall survival (OS) compared to surgery alone in...

Posted by : Pr. Franck BONNETAIN, Dr. Frederic FITENI, Dr. Sophie PAGET-BAILLY
Journal name : European Journal of Surgical Oncology

sample

Docetaxel, cisplatin, and 5-fluorouracil (DCF) significantly improved overall survival in metastatic gastroesophageal...

Posted by : Pr. Franck BONNETAIN, Dr. Sophie PAGET-BAILLY, Dr. Frederic FITENI
Journal name : Cancer Medecine

sample

AbstractBackground:Frailty is highly prevalent in elderly people. While significant progress has been made to...

Posted by : Dr. Dewi VERNEREY, Dr. Amélie ANOTA, Dr. Sophie PAGET-BAILLY, Mme. Audrey FOUBERT, Mme. Astrid POZET, Pr. Franck BONNETAIN
Journal name : BMC Geriatrics

sample

The measurement of the quality of life in terms of health of people undergoing treatment for cancer is developing. Th is...

Posted by : Pr. Franck BONNETAIN, Dr. Guillaume MOUILLET, Mme. Joëlle FRITZSCH, Dr. Sophie PAGET-BAILLY, Mme. Ikram ES-SAAD
Journal name : La revue de l'infirmière

sample

AbstractAim: Adjuvant clinical trials in early human epidermal growth factor receptor 2 (HER2)-positive breast cancer...

Posted by : Dr. Sophie PAGET-BAILLY, Mme. Julie HENRIQUES
Journal name : European Journal of Cancer

sample

AbstractOverall survival (OS) has been considered as the most relevant primary endpoint but trials using OS often...

Posted by : Pr. Franck BONNETAIN, Dr. Sophie PAGET-BAILLY, Dr. Dewi VERNEREY, Dr. Amélie ANOTA, , Dr. Frederic FITENI
Journal name : Expert Review of Anticancer Therapy

sample

AbstractBackground: Genome-wide association studies (GWAS) have to date identified 94 genetic variants (single...

Posted by : Dr. Sophie PAGET-BAILLY, Mme. Julie HENRIQUES
Journal name : Breast Cancer Research

Latest News

Latest tools

The management of locally advanced pancreatic cancer (LAPC) patients remains controversial. Better discrimination for...

Posted by : Pr. Franck BONNETAIN, Dr. Sophie PAGET-BAILLY, Dr. Dewi VERNEREY

Discover Pr Bonnetain's keynote during the canceropôle IDF' seminar on rare tumours.Listen to the keynote here.Discover...

Posted by : Dr. Sophie PAGET-BAILLY, Pr. Franck BONNETAIN

2015-2017 © Copyright - UMQVC.org

Website by Pearlweb